Verbascoside at 20 mg/kg doses prevented the development of osteoarthritis in rats by lowering proinflammatory interleukin (IL-1β, IL-6) and tumor necrosis factor (TNF)-α [55]. This evidence concerns the gene IL1B and osteoarthritis.